Cooper Consumer Health Poised To Double In Size With Viatris Acquisition
Cooper Consumer Health says it is set to become a “truly pan-European pure-play leader in consumer healthcare” with the acquisition of Viatris' OTC business in a $2.2bn deal.
Cooper Consumer Health says it is set to become a “truly pan-European pure-play leader in consumer healthcare” with the acquisition of Viatris' OTC business in a $2.2bn deal.